FAQ

The Tide is a medical clinic in Houston, Texas, located adjacent to the Texas Medical Center at 6909 Grand Boulevard. We provide hormone care, medical weight loss, peptide therapy with FDA-approved and permitted compounded medications, injury recovery care, sexual wellness, immune and inflammation care, longevity care, NAD+ and IV therapy, and advanced lab testing. Unlike medspas, this medicine is our entire focus.

We don’t offer injectables, facials, laser treatments, or any of the other services medspas typically bundle with peptide therapy. Peptides and related medicine are the only thing we do. That changes what our providers train for, how we staff the clinic, how we source our peptides, and how much time we spend on patient education.

It also changes what we’ll tell you. Because we aren’t trying to upsell you on a facial when peptides aren’t the right answer, we can be honest when they aren’t.

Our clinic is at 6909 Grand Boulevard, Houston, Texas 77054 — adjacent to the Texas Medical Center. We’re accessible from across the Houston metro including the Museum District, Bellaire, Rice Village, the Heights, West University, Galleria, River Oaks, Memorial, and the broader TMC area. Free parking is available on site.

We offer peptide therapy, medical weight loss with GLP-1 medications (semaglutide, tirzepatide), men’s hormone health (TRT for confirmed low testosterone), women’s hormone health (HRT and menopause care), injury recovery care, longevity care, growth hormone evaluation (which may include compounded sermorelin, not FDA-approved), sexual wellness (including bremelanotide/PT-141 and off-label oxytocin), immune and inflammation care (including LDN), NAD+ and IV therapy, and advanced lab testing with genetic analysis. Each service has its own dedicated page with the specifics.

No. Anabolic steroids are modified testosterone molecules with specific anabolic and androgenic effects. Peptides are short chains of amino acids that act as signaling molecules at specific receptors. They are a completely different drug class with different mechanisms, different effects, and different safety profiles.

Peptide therapy addresses a wide range of clinical goals depending on the specific peptide. GLP-1 peptides like semaglutide and tirzepatide treat metabolic disease and obesity. Sermorelin, a compounded growth hormone–releasing peptide that is not FDA-approved, may be considered after evaluation of age-related GH-axis changes. BPC-157 and TB-500 are not FDA-approved, and The Tide does not offer them. Bremelanotide (Vyleesi) is FDA-approved for low sexual desire (HSDD) in premenopausal women; other uses are off-label. The right peptide depends on what you’re trying to treat — which is the work of consultation, not a script you fill from a website.

It depends on what you’re trying to do and what the evidence supports for that goal. For some goals — weight management with GLP-1 agonists, for example — the evidence is strong and response rates are high. For others, the evidence is thinner and results are more variable.

A consultation is the only way to give you a real answer, because the answer depends on your specific case.

No — and honestly, we prefer patients who don’t. Our approach is to start with your goal, not a peptide name. If you arrive asking for a specific peptide, that’s fine; we’ll still work through whether it’s the right one for your situation.

Our patients tend to be Houston professionals in their 30s through 60s who are serious about their health and want a clinic that thinks like they do. Many are seeking medical weight loss with GLP-1 therapy. Many are addressing hormone changes — perimenopause, menopause, low testosterone, andropause. Some are working through recovery from an injury. Some want preventive, biomarker-based care. Some are managing complex conditions like autoimmune disease or long COVID. What unites them: they want evidence-based medicine, not aspirational marketing.

The Tide is a provider-led outpatient clinic focused on hormone health, medical weight loss, sexual wellness, longevity, and related lab-guided care. Every plan starts with a consultation and appropriate lab work, and treatment decisions are made individually by your provider.

Yes. Medical weight loss with GLP-1 therapy is one of our core services. When clinically appropriate, we prescribe FDA-approved brand-name GLP-1 medications — Wegovy and Ozempic (semaglutide) and Zepbound and Mounjaro (tirzepatide). In limited cases, and only where permitted under current FDA rules, your provider may prescribe a compounded semaglutide or tirzepatide preparation from a licensed pharmacy. Compounded medications are not FDA-approved and are not generic versions of these brand-name products. Our medical weight loss program includes baseline labs, provider consultation, supervised titration, and ongoing monitoring. See our Medical Weight Loss page for the full picture.

Yes. We offer comprehensive TRT for men with documented low testosterone, including testosterone cypionate or enanthate injections and, when clinically indicated, adjunct medications: HCG or anastrozole (off-label in men) or gonadorelin (compounded; not FDA-approved). Our approach emphasizes proper baseline workup, fertility discussions for men who may want children in the future, and structured monitoring — not the transactional “low-T clinic” pattern. See our Men’s Hormone Health page.

Yes. We offer comprehensive HRT for women in perimenopause, menopause, and post-menopause, using bioidentical estradiol, micronized progesterone, and, when appropriate, testosterone for women (off-label). Compounded preparations are not FDA-approved. We also work with women on hormone concerns in earlier life stages. See our Women’s Hormone Health page for details on our approach to menopause care, perimenopause management, and bioidentical hormone therapy.

Yes. Menopause and perimenopause care is a core part of our Women’s Hormone Health service. We address vasomotor symptoms (hot flashes, night sweats), sleep disruption, mood changes, libido, vaginal symptoms, and bone health. We use bioidentical estradiol and micronized progesterone in evidence-based protocols, and we discuss the WHI re-analyses and modern menopausal hormone therapy evidence honestly with patients. Houston has limited high-quality menopause care, and we built this service to fill that gap.

Yes, when clinically appropriate. Low-dose naltrexone is an off-label use: naltrexone is FDA-approved, but not at low doses or for these conditions. A provider may discuss it for selected patients with chronic inflammatory or pain conditions, with monitoring and coordination with your specialty care. Our Resources article on LDN reviews the published research and its limits.

Yes. Long COVID care is part of our Immune & Inflammation service. We approach long COVID as legitimate medical territory rather than dismissing it. Options for post-viral syndrome patients may include off-label low-dose naltrexone and other supportive care, discussed case by case. We will not promise miracle outcomes — the evidence base is still developing — but we will engage seriously with the condition and coordinate with your other providers.

Yes, in some cases. Low-dose naltrexone has been studied in small trials for fibromyalgia; its use is off-label, and a provider may discuss it as an option. We also address related musculoskeletal concerns through our recovery care. We are not a primary pain management practice and do not prescribe controlled substances; for patients on chronic opioid therapy, LDN cannot be used until they have transitioned off opioids under their pain management physician’s care.

Yes. We offer NAD+ infusions and NAD+ injections. NAD+ is not FDA-approved for these uses, and we make no claims about specific health benefits. NAD+ IV therapy is delivered in our clinic with proper medical oversight. We are not a “drip lounge” — our IV protocols are clinical and structured, with appropriate monitoring during infusion.

Yes. Sexual Wellness is a dedicated service. We address erectile dysfunction with PDE5 inhibitors and hormone optimization, low libido with options such as bremelanotide (FDA-approved as Vyleesi only for premenopausal women with HSDD; other uses are off-label) and off-label oxytocin, and broader sexual function concerns with appropriate workup. We treat sexual wellness as legitimate medicine rather than as a transactional script — meaning we look for underlying causes (hormonal, vascular, psychological, medication-related) and address them where possible, not just write prescriptions.

Yes. Recovery & Regenerative is a dedicated service. We focus on diagnosis, rehabilitation coordination, and the factors that slow healing for tendinopathy, post-surgical recovery, soft-tissue injuries, and chronic musculoskeletal concerns. Many of our patients are active people in their 30s through 60s working through specific injuries or chronic recovery issues. We coordinate with orthopedic surgeons and sports medicine physicians when appropriate.

Yes, but we approach longevity as evidence-based medicine rather than aspirational marketing. Our Longevity service focuses on structured biomarker tracking and prevention, with hormone care where clinically indicated. We do not promise to reverse aging or extend lifespan.

Yes. Advanced Labs & Genetics is a dedicated service. We offer comprehensive lab panels well beyond standard primary care — including detailed hormone panels, advanced lipid markers, inflammatory markers, micronutrient testing, and where clinically appropriate, genetic testing for medication metabolism, cardiovascular risk, and methylation pathways. The labs are interpreted clinically with you, not just emailed as a PDF.

Yes, as part of our Immune & Inflammation service. For Hashimoto’s specifically, a provider may discuss off-label low-dose naltrexone where appropriate, along with thyroid hormone management in coordination with your existing physician, and addressing root contributors to autoimmune flares. We coordinate with your endocrinologist or primary care physician on thyroid hormone replacement.

We offer adjunctive support for IBD patients alongside their gastroenterology care. Low-dose naltrexone (off-label) has been studied in small trials as adjunctive therapy and may be discussed. The Tide does not offer BPC-157 or other unapproved peptides. We do not replace appropriate gastroenterology management of IBD, and we coordinate with your specialist.

“Safe” is a useful word only in context. FDA-approved peptides have well-characterized safety profiles from clinical trials. Peptides without FDA approval have less formal human safety data, and we discuss what is and isn’t known for each one.

The risk profile depends on which peptide, at what dose, in what patient, for what duration, and — critically — from what source. Underground-sourced peptides from research-chemical vendors carry meaningful risk of contamination, misdosing, and infection. We don’t work with those.

It varies widely by peptide. GLP-1 agonists commonly cause GI side effects, especially during titration. Growth hormone secretagogues can cause water retention, joint discomfort, and blood sugar changes. PT-141 can cause nausea, flushing, and transient blood pressure changes. LDN can cause vivid dreams in the first weeks. Specific side effects are reviewed during consultation for any peptide we recommend.

Often, yes — but this is exactly what the provider review is for. Some peptides interact meaningfully with cardiovascular medications, diabetes medications, psychiatric medications, and thyroid replacement. We review your full medication list before prescribing anything.

Yes. We don’t prescribe to patients with active malignancy in most cases, during pregnancy or breastfeeding, to patients who decline basic lab work or follow-up, or to patients who are concurrently using underground-sourced peptides. We also won’t prescribe peptides outside their evidence base simply because the patient wants them.

It depends on the peptide and the cancer history. Some peptides — particularly growth hormone secretagogues and certain regenerative peptides — are contraindicated in patients with active cancer or recent cancer history because they could theoretically promote cell proliferation. Other medications may be appropriate in some contexts. This is a case-by-case decision made during consultation with your full history.

No. We do not prescribe peptides during pregnancy or breastfeeding because the safety data is insufficient. Patients who become pregnant on therapy should pause treatment and contact us. We do prescribe to women who are planning pregnancy, with adjustments to protocols and timing.

The safety profiles are different in important ways. FDA-approved peptides go through formal clinical trials with characterized safety endpoints. Peptides without FDA approval have not had their safety established in well-controlled human trials; most of what is known comes from preclinical data, with less formal human safety data. We work only with licensed pharmacies that meet specific quality standards, and we discuss these considerations openly with patients.

Stop the medication and contact our clinical team immediately. Many side effects are mild (GI symptoms during GLP-1 titration, vivid dreams when starting LDN, injection-site reactions), but serious reactions can occur. We have protocols for managing significant adverse events and we are reachable through our patient portal during business hours and through after-hours channels for urgent issues.

Yes, when relevant. Several peptides require cardiovascular consideration. PT-141 can transiently affect blood pressure. Some growth hormone protocols affect glucose metabolism and may require monitoring in patients with cardiovascular risk factors. TRT requires baseline lipid evaluation and ongoing monitoring. Our baseline workup captures the relevant cardiovascular markers, and we adjust protocols accordingly.

Typically two to three weeks from consultation to first dose. That includes intake, lab work (if not already current), provider treatment planning, and dispensing through the pharmacy. Some programs move faster when recent labs are available; some take longer when additional workup is needed.

The first consultation requires an in-person visit at our Houston office (6909 Grand Boulevard, adjacent to the Texas Medical Center). After we have established care and completed your baseline workup, follow-up visits and prescription refills can often be handled via telehealth for established patients located in Texas.

We provide care to patients located in Texas only. Our providers are licensed in Texas, and telehealth follow-up is available only for established patients who are physically located in Texas at the time of the visit.

The initial visit is 45 minutes. We discuss your goals, review your medical history, walk through any current symptoms or concerns, and decide together what workup is appropriate. We will not prescribe in the first visit. Prescription decisions follow your baseline labs and a clinical decision. The consultation is the start of an evaluation, not the prescription itself.

The lab panel depends on what we’re evaluating. A typical baseline includes a comprehensive metabolic panel, complete blood count, lipid panel with advanced markers, hemoglobin A1c, fasting insulin, and inflammatory markers (hsCRP). Hormone-related visits add full hormone panels with appropriate sensitivities. GH-related visits add IGF-1 and IGFBP-3. Immune visits add ANA, autoimmune markers, vitamin D, and condition-specific markers. Most labs are done at LabCorp or Quest near you.

You’ll have structured check-ins with your provider on a schedule appropriate to your program — typically at 6 to 12 weeks after starting, then quarterly for stable patients. Between visits, you can message the clinical team through our patient portal. Labs are repeated at defined intervals, and your protocol is adjusted based on how your body responds.

Peptides are dispensed through licensed pharmacies. Most are shipped directly to your home in temperature-controlled packaging. Some FDA-approved medications can also be filled at retail pharmacies. We discuss the dispensing pathway during consultation and you’ll know exactly where your medications are coming from.

It depends on the protocol. For most peptide protocols, we repeat relevant labs at 90 days after starting and every 6 months thereafter. Hormone optimization protocols typically require lab checks at 6 weeks and 3 months during dose-finding, then every 6 months once stable. Some specific situations require more frequent checks.

Yes. No program locks you in. Some medications have specific tapering considerations we’ll walk you through, but the decision to continue or stop is always yours.

Yes. Established patients communicate with the clinical team through our HIPAA-compliant patient portal. The portal handles secure messaging, lab result review, prescription requests, and visit scheduling. We do not handle clinical questions through email or our website contact forms — those channels are not appropriate for protected health information.

For medical emergencies, call 911. For urgent clinical questions during business hours, message us through the patient portal — we monitor it actively. After-hours urgent clinical issues for established patients are handled through our on-call line, the number for which is provided to active patients. Our website contact form is for general inquiries only, not urgent clinical questions.

FDA-approved peptides are prescribed like any other FDA-approved medication. Peptides that are not FDA-approved have a regulatory status that varies by peptide and has been changing. We discuss the current regulatory status of any peptide we recommend during consultation.

Research-chemical peptides sold online are a different category, and not one we participate in.

Yes. FDA guidance on certain compounded peptides has evolved over the last few years, with specific peptides being added to or removed from the lists permitted for compounding. We track these changes continuously and adjust our formulary to stay within the current regulatory framework.

No. Research peptides sold online with “for research purposes only” disclaimers are not legally available for human use, are not pharmaceutical-grade, and carry meaningful risk of contamination, misdosing, and infection. We work exclusively with FDA-approved pharmaceuticals and licensed compounding pharmacies. Patients currently using research peptides are encouraged to stop and discuss FDA-approved options with a licensed provider.

FDA-approved brand-name medications (Wegovy, Ozempic, Mounjaro, Zepbound) are manufactured under FDA oversight and supported by full Phase III evidence. Compounded semaglutide and tirzepatide preparations are made by licensed compounding pharmacies; they are not FDA-approved, the FDA does not review them for safety, effectiveness, or quality, and they are not generic versions of, or interchangeable with, the brand-name products. The FDA has stated that compounding these drugs is generally not appropriate when the FDA-approved product is not in shortage. Our default is the FDA-approved product; a compounded preparation is used only when clinically justified and consistent with current regulations.

We use licensed pharmacies with documented quality systems, third-party testing, and clean regulatory histories. Prescriptions are typically sent to one of the licensed pharmacies we work with, and you may ask us to send your prescription to a different licensed pharmacy.

We offer two consultations. The Targeted Consult is $49 (peptide therapy, weight loss, HRT, or TRT; in person or by video) and the Comprehensive Consult is $349, which includes lab work and a body composition scan (in-person visit). See pricing. Treatment costs depend on your plan, the monitoring required, and any medication, and are reviewed with you before anything begins. Our Programs page has specific starting prices for each offering.

We are transparent about pricing before you enroll. There are no hidden fees and no auto-renewals without consent. Medication costs are separate from program fees and are reviewed with you before you start.

Most peptide therapy is not covered by insurance, because compounded and off-label medications are typically not covered. For FDA-approved peptides being used on-label — like Ozempic for type 2 diabetes — we can provide documentation to support your own insurance submission, but we don’t bill insurers directly.

Some patients use HSA/FSA funds for consultations and certain program costs; check with your plan.

Programs are billed month-to-month or per course, depending on structure. You can stop at any time. We don’t use long-term contracts or multi-month prepayment requirements.

For most consultations and many medications, yes. HSA and FSA funds typically cover provider consultations, medical labs, and prescription medications. Some compounded medications and some optional services may not qualify; check with your plan administrator. We can provide receipts and documentation suitable for HSA/FSA submission.

Costs vary by medication and dose. FDA-approved branded medications (Wegovy, Mounjaro, Zepbound) typically cost $1,000 to $1,400 per month at retail without insurance, though manufacturer savings programs can substantially reduce this. Our medical weight loss program fee covers the consultation, monitoring, and clinical oversight; medication costs are separate. We discuss specific costs during consultation.

TRT pricing depends on the protocol. Testosterone cypionate or enanthate injections are inexpensive (often under $50/month at retail). Adjunctive medications (gonadorelin, HCG, anastrozole) add modest additional cost. Our hormone health program fee covers the consultation, lab review, and ongoing monitoring; medication costs are separate. Total monthly cost for most TRT protocols at The Tide is in the $250 to $400 per month range including all clinical services.

LDN itself is inexpensive — typically under $50 per month at most compounding pharmacies. The clinical service fees for our Immune & Inflammation program cover consultation, lab review, and ongoing monitoring; the LDN medication cost is separate and modest.

For larger upfront workups (initial labs plus consultation), we can sometimes split the cost across multiple billing cycles. We do not offer financing for ongoing program costs — programs are billed month-to-month, so you can pause or stop if cost becomes a concern.

Yes, when clinically appropriate. GLP-1 and dual agonists are a cornerstone of our metabolic program. We consider medical history, BMI or metabolic markers, lifestyle factors, and other options before prescribing, and we adjust based on how you tolerate the therapy.

No. BPC-157 is not FDA-approved, and The Tide does not offer it. For background on its regulatory status, see our article on the legal status of BPC-157.

When clinically appropriate, a provider may prescribe sermorelin after evaluation. Sermorelin is compounded and not FDA-approved. We monitor IGF-1 throughout, and we don’t market it as anti-aging therapy. See Growth Hormone Support.

Yes. The brand-name bremelanotide product Vyleesi is FDA-approved for hypoactive sexual desire disorder in premenopausal women; use of bremelanotide (PT-141) in men or postmenopausal women is off-label. We prescribe it when appropriate — as Vyleesi or, where clinically appropriate, as a compounded preparation (compounded medications are not FDA-approved) — and discuss realistic expectations. PT-141 is not a treatment for erectile dysfunction.

No. TB-500 and thymosin beta-4 are not FDA-approved, and The Tide does not offer them.

Yes. We offer both NAD+ subcutaneous injections (which patients self-administer) and NAD+ IV infusions in our clinic. NAD+ is not FDA-approved for these uses. Your provider discusses which, if either, is appropriate.

Oxytocin is FDA-approved (as Pitocin) only for use in labor and postpartum. Intranasal or other use for sexual wellness is off-label, and compounded preparations are not FDA-approved. A provider may discuss it as an off-label option after evaluation, as part of broader sexual wellness care. We make no claims about its benefits for these uses.

MOTS-c is not FDA-approved, and The Tide does not offer it.

No. AOD-9604 is not FDA-approved and does not have a legal compounding pathway, so we do not offer it.

We do not prescribe Melanotan II. Its broad melanocortin activity has documented associations with atypical pigmented lesions and possible melanoma risk. For low sexual desire, a provider may discuss bremelanotide (Vyleesi), which is FDA-approved for HSDD in premenopausal women.

The Peptide Library lists peptides we research for patient education. Inclusion in the library does not mean a peptide is offered at The Tide. If you’ve read about a peptide not in the library, it’s either because we don’t consider the human evidence sufficient to prescribe, because it falls outside current regulatory pathways, or because it’s outside our scope of practice. We’re happy to discuss specific peptides on a consultation.

No. We work exclusively with FDA-approved pharmaceuticals and licensed compounding pharmacies that meet specific quality standards. Research-only compounds purchased from research peptide vendors do not meet pharmaceutical quality standards and we cannot incorporate them into clinical care responsibly.

TRT clinics specialize in testosterone replacement and add peptides as an adjunct. The Tide is a broader hormone and metabolic practice — testosterone is one tool we use, alongside many others, and every plan starts with a full workup rather than a default protocol.

Functional medicine practices typically address a wide range of chronic illness through nutrition, supplementation, lifestyle, and selective use of medications. The Tide is more focused: we are a peptide and pharmaceutical-medicine practice that approaches things with the rigor of conventional medicine and the use of off-label and compounded therapies only where clinically appropriate and permitted. Some functional medicine work overlaps with what we do (lab interpretation, root-cause thinking); we differ in our depth on peptide pharmacology and our pharmaceutical-first approach to clinical decisions.

Longevity clinics often focus broadly on aging optimization with extensive supplementation, advanced diagnostics, and aspirational marketing. The Tide focuses on the medications and peptides themselves — we offer longevity services, but we don’t promise to extend lifespan or reverse aging. We focus on evidence-based care and are honest about the limits.

Telehealth-only peptide platforms (Hone, Marek, others) operate at scale with brief consultations, often without in-person visits, often with limited specialty depth. The Tide operates as a real medical practice with in-person initial consultations at our Houston clinic, longer consultation times, and more clinical depth. Telehealth-only platforms work well for some patients with straightforward needs; The Tide is a better fit for patients with complex situations or who want a more involved clinical relationship.

It depends. For routine adult preventive care, you should have a primary care doctor regardless of whether you work with us. For peptide therapy specifically, your primary care doctor is unlikely to have specialized expertise in peptide pharmacology — this is what we focus on. Many of our patients see us for hormone, metabolic, or peptide care and keep a separate primary care relationship for general health, which we coordinate with as relevant.

Often yes, sometimes with specific considerations. Patients with autoimmune disease, cardiovascular history, prior cancer, complex medication regimens, or other significant medical history are welcome — we just need the full picture during consultation so we can make appropriate decisions. Some conditions limit which peptides are appropriate; our job is to figure out what’s available given your specific situation.

Timeline varies substantially by peptide and indication. GLP-1 medications produce noticeable appetite changes within the first week and meaningful weight loss over months. We discuss expected timelines for your specific protocol during consultation.

In the clinical trials that supported FDA approval of Wegovy (semaglutide), average weight loss was approximately 15 percent of body weight at one year at the therapeutic dose. In the trials for Zepbound (tirzepatide), average weight loss was approximately 20 percent at one year. These results come from the FDA-approved products; compounded preparations were not studied in these trials. Individual results vary widely — some patients lose substantially more, others less. Long-term outcomes depend heavily on whether you maintain the medication, build sustainable lifestyle changes during treatment, and have appropriate medical oversight. We are honest about realistic expectations during consultation.

Then we stop them. We are not interested in continuing therapy that isn’t producing benefit. If a peptide isn’t working at the expected timeline, we reassess: was the dose adequate, was there a confounding factor, would a different peptide be more appropriate, or is peptide therapy simply not the right intervention for your situation? We will tell you honestly when we think continued treatment isn’t worth it.

It depends on what we’re treating. Some treatments (hormone therapy, GLP-1 weight maintenance) may continue long-term. Some treatments (PT-141, PDE5 inhibitors) are used as-needed rather than continuously. We discuss expected duration during consultation and reassess at follow-ups.

It depends on the peptide and what changes were made during therapy. Weight loss with GLP-1 medications often partially regresses without the medication unless substantial lifestyle changes were established during therapy. Effects of hormone therapy fade once it stops. We discuss durability of effects honestly during consultation.

Strongly yes. Medications do not replace the foundations. A patient sleeping 5 hours nightly, eating poorly, and chronically stressed will get worse outcomes from peptide therapy than a patient with foundational work in place. We discuss foundations honestly during consultation and integrate them into program structure where relevant.

Houston has the largest medical complex in the world (the Texas Medical Center), a sophisticated patient population, and substantial demand for the kind of evidence-based peptide medicine that has been under-served by conventional Houston-area practices. Many Houston patients seeking peptide therapy have been forced to choose between medspa-style practices and out-of-state telehealth platforms; we built The Tide to fill that gap with clinic-grade medical care.

We are located adjacent to the Texas Medical Center at 6909 Grand Boulevard, but we are an independent medical practice. We are not affiliated with Houston Methodist, MD Anderson, Texas Children’s, or any TMC institution. Our proximity to TMC matters for patient access (most TMC-area patients can walk to us) and for coordination with TMC specialists when our patients also see them.

Yes. We see patients from across Texas. Many patients travel to Houston for the initial in-person consultation and then continue through telehealth follow-ups. Our location adjacent to TMC makes air travel from elsewhere in Texas straightforward (Hobby Airport is 15 minutes away). We can refer to LabCorp or Quest locations near you for ongoing lab work.

Our patients come from across the Houston metro. Frequent neighborhoods include the Texas Medical Center area, Museum District, Bellaire, Rice Village, the Heights, West University, Galleria, River Oaks, Memorial, Montrose, Midtown, and Sugar Land. Many also come from the surrounding Houston suburbs and from elsewhere in Texas.

Yes. Free parking is available on site at 6909 Grand Boulevard. Our location is also accessible from major Houston arteries (Holcombe, Main, Fannin) and is a short drive from most central Houston neighborhoods.

The clinic is open Monday through Friday from 9:00 AM to 5:00 PM Central Time. Telehealth follow-ups for established patients can sometimes be scheduled outside these hours. The patient portal is available 24/7 for established patients to send messages to the clinical team.

No. We work with licensed compounding pharmacies and standard retail pharmacies that fill prescriptions and ship directly to you (or to your local pharmacy for retail medications). This allows us to focus our clinical resources on the medical work rather than running a pharmacy.

Book a consultation through our website. We’ll confirm scheduling within one business day. The first visit is 45 minutes — the right place to discuss whether our care is a fit for your situation. We will not prescribe in the first visit. Prescription decisions follow your baseline labs and a clinical decision after the consultation.

If you have recent labs (within the past 6 months), bring them or send them in advance through the patient portal once you’re scheduled. Have a list of your current medications and supplements. Have a clear sense of what brought you in — what you’re trying to address, what you’ve already tried, and what realistic outcome you’re hoping for. We do the rest during the consultation.

No. We don’t require referrals. Patients self-refer to us directly through the website or by calling the clinic.

Yes, if you’d like. Many patients find it helpful to have a partner present, especially when discussing hormone changes, sexual wellness, or major lifestyle changes. Just let us know during scheduling.

That’s a fine reason to book a consultation. We see many patients who are evaluating whether peptide therapy is a fit before committing. The consultation itself is a service — you’ll leave with a clearer picture of what your options are, what evidence supports them, and what reasonable next steps look like, regardless of whether you proceed with us.